Mebendazole as Adjuvant Treatment for Colon Cancer
Recruiting · NCT03925662 · Interventional (participants receive a specific treatment) · Lead sponsor: Sherief Abd-Elsalam
View the official record on ClinicalTrials.gov →Interventions studied
Folfox with avastinMebendazole
What this trial is about
mebendazole treating colon cancer
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Colorectal cancer stage 4.
Exclusion criteria
- Agranulocytosis
- Pregnancy
- Allergy to mebendazole.
Where it is running
1 location listed.
- Sherief Abd-Elsalam - Cairo, Egypt